UK ePI Task Force evidence review published in TOPRA’s Regulatory Rapporteur

TOPRA has published a UK ePI Task Force evidence review on the use of ePILs in their international journal, Regulatory Rapporteur.

TOPRA has published a UK ePI Task Force evidence review on the use of electronic Patient information leaflets (ePILs).

The UK ePI Task Force is a cross-industry initiative led by PAGB, the consumer healthcare association, ABPI and BGMA. The purpose is to facilitate a move to user-centered, digital-first medicines information in the UK, that is inclusive and accessible for all, better for patients and the environment.

The evidence review has been published in TOPRA’s Regulatory Rapporteur, the international journal for professionals in regulatory affairs, and was co-authored by Marie Woe, Kathryn Sharpe and Erika Aparicio on behalf of the UK ePI Task Force.

It collates existing data with a focus on how patients and healthcare professionals currently access patient information leaflets (PILs) and healthcare information globally, and the challenge and opportunities of the transition from paper PILs to ePILs in the UK.

PAGB members can access the article on the open link below – please note you will need to be logged into your members account to view and access the link on this page.

Related news

Self-Care Week blog post from Mark Burdon

Our final blog post this Self-Care Week delves into the pivotal role that pharmacies are playing in the Government’s 10 Year Health Plan. Mark explores the impact of Pharmacy First paving the way, the current challenges that the Government should be prioritising and how digital tools can bring support pharmacists as they widen access to self-care and help streamline patient journeys.

Self-Care Week blog post from Mark Burdon

Self-Care Week blog post from Michelle Riddalls OBE

To mark Self-Care Week, Michelle Riddalls OBE has authored a blog post on the important role that reclassification has to play in the Government’s agenda to move from sickness to prevention and reduce pressures on primary care. Through greater reclassification of over-the-counter products, we can improve access to self-care, reduce GP visits and empower patients, whilst delivering up to £1.4 billion in savings to NHS prescribing costs annually.

Self-Care Week blog post from Michelle Riddalls OBE
View all